Each solution too
We reach different targets and links in mental health.
Our technology allows us to offer a solution for each case: mental health, emotional wellness, occupational wellness, chronic diseases, research and consulting.
Eating disorder
The app helps patients identify emotions, treatment goals, communicate with their clinical team, have an immediate resource bank and be able to monitor their improvement. All this quickly and easily from their mobile device. In addition, the clinical team, thanks to the eB2 MindCare Portal, shares with patients indicators of variation in the patient’s usual functioning on which the application bases its artificial intelligence algorithms.
More information: https://itasaludmental.com/noticias/noticias/link/405
Product: eB2 MindCare
Relapse prevention in mental health
PreCARE will provide a validated and easy-to-use solution to help mental health professionals detect relapses early and, at the same time, will contribute to improving the follow-up of mental health patients. It is being developed by the consortium formed by the GTS Research Group of the Universidad Carlos III de Madrid (GTS-UC3M), the company Evidence-Based Behavior (eB2) and two mental health care centers belonging to the Hospitaller Order of Saint John of God (SJD), the Clínica Nuestra Señora de la Paz (CNSP) and the Centro San Juan de Dios de Ciempozuelos (CSJD).
More information: https://precare.webs.tsc.uc3m.es/
Product: eB2 MindCare, eB2 Research, eB2 Monitor&Predict
Suicide Prevention
Implementing evidence-based interventions could prevent many of these deaths. Currently, mobile phones allow us to ask people at risk of
Product: eB2 Research, eB2 Monitor&Predict
Prevention of Delirium Events
B2 EarlyDel is a system for predicting and managing delirium events, assessing the risk of delirium or acute confusional state in patients over 65 years old in hospital and care settings. It is based, on one hand, on artificial intelligence, and on the other, on the internationally standardized protocols NANDA, NIC, and NOC, abbreviated as “NNN,” for nursing diagnosis and intervention. EarlyDel has been developed in collaboration with the Gregorio Marañón Hospital thanks to the Innobuyer Program.
More information: https://innobuyer.eu/selected_projects/earlydel/
Product: eB2 Monitor&Predict
Oncology
LumiCare was created with the aim of offering a comprehensive personalized medicine solution for the care of women with cancer, based on dietary intervention, lifestyle habits, and emotional well-being, defining new biomarkers and therapeutic approaches in all these areas of oncology. The project is carried out in collaboration with TNC Nutrición Terapéutica (TNC TERAPIA), CNIO, UC3M, and Hospital 12 de Octubre in Madrid.
Product: eB2 MINDCARE
Risk Factors in Cognitive Decline
More than 50% of cases of Cognitive Decline are undetected. In the case of mild cognitive decline, up to 90% would remain undiagnosed.
Dendrite aims to implement Precision Personalized Medicine to prevent and early identify cognitive decline in adults aged 55 to 70 years and promote healthy aging.
Thanks to eB2 Research, Dendrite can collect data through the eB2 MindCare app, questionnaires, games, and automatically gather information on sleep hours, physical activity, and mobile phone usage. All this information will be valuable in drawing conclusions about the influence of these factors on cognitive decline.
More information: http://www.proyectodendrite.es/
Product: eB2 RESEARCH
Emotional Well-being in the Workplace
After the pandemic, in 2022, UC3M, through HR and Organizational and Occupational Risk Prevention, launched the “MensSana” program with the aim of improving employees’ mental health and emotional well-being, in collaboration with Evidence-Based Behavior (eB2) and POP Empower.
More information: https://www.uc3m.es/hr/menssana
Product: eB2 MINDCARE
Early Detection of Crises in Autism
The GTS group of UC3M, in collaboration with the company Evidence-Based Behavior (the developer), has designed the CuidaTEA app within the PETRA project of the Universidad Carlos III de Madrid, a project selected by Indra and the Universia Foundation of Banco Santander in the “III Call for Research Project Grants on the Development of Accessible Technologies.”
More information: http://cuidatea.webs.tsc.uc3m.es/
Product: eB2 RESEARCH
How can we help you?
Contact us to receive accurate information adapted to your specific case.
We Reach You
